Bill > S0676

Introduced Session

Expanding the categories of persons who may prescribe brand name drugs under the prescription drug program when medically necessary; requiring a hospital to provide specified advance notice to certain obstetrical physicians before it closes its obstetrical department or ceases to provide obstetrical services; requiring the Board of Nursing to establish a committee to recommend a formulary of controlled substances that may not be prescribed, or may be prescribed only on a limited basis, by an advanced registered nurse practitioner; designates "The Barbara Lumpkin Prescribing Act"; requiring that certain health insurers that do not already use a certain form use only a prior authorization form approved by the Financial Services Commission in consultation with the Agency for Health Care Administration, etc.

Committee Categories

Denise Grimsley (R)*,  Thad Altman (R),  Aaron Bean (R),  Oscar Braynon (D),  Dwight Bullard (D),  Jeff Clemens (D),  Nancy Detert (R),  Miguel Diaz de la Portilla (R),  Anitere Flores (R),  Audrey Gibson (D),  Gwen Margolis (D),  Darren Soto (D), 

Other Sponsors (3)

Laid on Table, companion bill(s) passed, see HB 423 (Ch. 2016-224), CS/HB 977 (Ch. 2016-231), HB 1241 (Ch. 2016-145), SB 586 (Ch. 2016-113) (on 03/09/2016)

Official Document